000285261 001__ 285261
000285261 005__ 20260219141329.0
000285261 0247_ $$2doi$$a10.1038/s41366-025-01914-2
000285261 0247_ $$2pmid$$apmid:41652183
000285261 0247_ $$2pmc$$apmc:PMC12913021
000285261 0247_ $$2ISSN$$a0307-0565
000285261 0247_ $$2ISSN$$a1476-5497
000285261 037__ $$aDZNE-2026-00203
000285261 041__ $$aEnglish
000285261 082__ $$a610
000285261 1001_ $$0P:(DE-2719)2812606$$aTöpfer, Philipp$$b0
000285261 245__ $$aSex-dependent associations of childhood maltreatment with obesity-related traits: results from the German National Cohort (NAKO).
000285261 260__ $$aAvenel, NJ$$bNature Publ. Group$$c2026
000285261 3367_ $$2DRIVER$$aarticle
000285261 3367_ $$2DataCite$$aOutput Types/Journal article
000285261 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1771506731_3093
000285261 3367_ $$2BibTeX$$aARTICLE
000285261 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285261 3367_ $$00$$2EndNote$$aJournal Article
000285261 520__ $$aThe relationship between childhood maltreatment (CM) and obesity is nuanced, and recent evidence suggests stronger associations between CM and obesity-related traits in females compared to males. This study aims to validate and extend these findings in a large sample from the German National Cohort (NAKO).The NAKO is a population-based cohort study including 204,744 adults. For the present analyses, 151,143 individuals (74,596 female) were included. CM was assessed using the Childhood Trauma Screener (CTS). From the CTS, an overall severity score (CTS sum score), a cumulative CM score (number of CM subtypes with at least moderate severity), and five CTS subtypes were considered as exposures. Obesity-related traits included anthropometric (height, weight, body mass index [BMI], waist circumference [WC]) and body fat markers (relative fat mass [rFM], subcutaneous [SAT], visceral adipose tissue [VAT]). Sex-stratified linear and logistic regression models were adjusted for age, education, and examination center to associate CTS-based scores with obesity-related traits.Associations of the CTS sum score with weight, BMI, WC, rFM, and SAT were stronger in females compared to males, while similar associations were observed for VAT. In both sexes, most obesity-related traits exhibited dose-response relationships with increasing numbers of CM subtypes. Compared to unexposed females, females with exposure to ≥3 CM subtypes had a higher risk for obesity (i.e., BMI ≥ 30 kg/m2; OR = 1.56; 95% CI: 1.43, 1.71) and high WC (i.e., WC ≥ 88 cm; OR = 1.39; 95% CI: 1.29, 1.50). In males, exposure to ≥3 CM subtypes was also associated with increased obesity risk (OR = 1.51; 95% CI: 1.32, 1.72) and high WC (i.e., WC ≥ 102 cm; OR = 1.31; 95% CI: 1.18, 1.44). Physical and emotional abuse exhibited the strongest average associations and were associated with the most outcomes.Associations of CM exposure with adult anthropometric and body fat markers are stronger in females compared to males.
000285261 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000285261 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000285261 650_2 $$2MeSH$$aHumans
000285261 650_2 $$2MeSH$$aMale
000285261 650_2 $$2MeSH$$aFemale
000285261 650_2 $$2MeSH$$aGermany: epidemiology
000285261 650_2 $$2MeSH$$aAdult
000285261 650_2 $$2MeSH$$aObesity: epidemiology
000285261 650_2 $$2MeSH$$aMiddle Aged
000285261 650_2 $$2MeSH$$aCohort Studies
000285261 650_2 $$2MeSH$$aSex Factors
000285261 650_2 $$2MeSH$$aBody Mass Index
000285261 650_2 $$2MeSH$$aChild
000285261 650_2 $$2MeSH$$aRisk Factors
000285261 7001_ $$aKlinger-König, Johanna$$b1
000285261 7001_ $$aSiewert-Markus, Ulrike$$b2
000285261 7001_ $$aSchipf, Sabine$$b3
000285261 7001_ $$aFischer, Beate$$b4
000285261 7001_ $$aSedlmeier, Anja M$$b5
000285261 7001_ $$00000-0001-7354-5958$$aHebestreit, Antje$$b6
000285261 7001_ $$00000-0003-3777-570X$$aAhrens, Wolfgang$$b7
000285261 7001_ $$aBerger, Klaus$$b8
000285261 7001_ $$00000-0002-6129-1572$$aBrenner, Hermann$$b9
000285261 7001_ $$aDo, Stefanie$$b10
000285261 7001_ $$aHeise, Jana-Kristin$$b11
000285261 7001_ $$aJaskulski, Stefanie$$b12
000285261 7001_ $$aKarch, André$$b13
000285261 7001_ $$00000-0002-9108-3360$$aKeil, Thomas$$b14
000285261 7001_ $$aKlett-Tammen, Carolina$$b15
000285261 7001_ $$aLeitzmann, Michael F$$b16
000285261 7001_ $$00000-0001-6645-0985$$aPeters, Annette$$b17
000285261 7001_ $$aSchmidt, Börge$$b18
000285261 7001_ $$00000-0002-0830-5277$$aSchulze, Matthias B$$b19
000285261 7001_ $$aWillich, Stefan N$$b20
000285261 7001_ $$aDörr, Marcus$$b21
000285261 7001_ $$aVölzke, Henry$$b22
000285261 7001_ $$00000-0002-6234-4955$$aMarkus, Marcello R P$$b23
000285261 7001_ $$aStracke, Sylvia$$b24
000285261 7001_ $$0P:(DE-2719)2811781$$aGrabe, Hans J$$b25$$udzne
000285261 7001_ $$aIttermann, Till$$b26
000285261 773__ $$0PERI:(DE-600)2101927-7$$a10.1038/s41366-025-01914-2$$gVol. 50, no. 2, p. 329 - 337$$n2$$p329 - 337$$tInternational journal of obesity$$v50$$x0307-0565$$y2026
000285261 8564_ $$uhttps://pub.dzne.de/record/285261/files/DZNE-2026-00203.pdf$$yRestricted
000285261 8564_ $$uhttps://pub.dzne.de/record/285261/files/DZNE-2026-00203.pdf?subformat=pdfa$$xpdfa$$yRestricted
000285261 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811781$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b25$$kDZNE
000285261 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000285261 9141_ $$y2026
000285261 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-11-07$$wger
000285261 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J OBESITY : 2022$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-11-07
000285261 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-11-07
000285261 9201_ $$0I:(DE-2719)5000001$$kAG Grabe$$lBiomarkers of Dementia in the General Population$$x0
000285261 980__ $$ajournal
000285261 980__ $$aEDITORS
000285261 980__ $$aVDBINPRINT
000285261 980__ $$aI:(DE-2719)5000001
000285261 980__ $$aUNRESTRICTED